MENU
CLSD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Clearside Biomedical (CLSD) Ownership - Who owns Clearside Biomedical?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
900 North Point Parkway
Phone
+1 678 270-3631
Employees
30
Web
https://www.clearsidebio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
77.36M
P/E Ratio
N/A
Total Cash
23.59M
Projected Growth
N/A
Total Debt
785K
Revenue
7.7M
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash/Share
0.31
Total Debt/Equity
N/A
Revenue/Share
0.11 USD as % of share price
Fundamentals
CLSD
Capitalization
77.4M
P/E Ratio
N/A
Risk (Beta)
2.07
Dividend Yield
N/A
Total Cash
23.6M
Total Cash/Share
0.31
Total Debt
785K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.11%
Revenue
7.7M
ROE
N/A
Book Value
-34.79M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
75K
Current Ratio
4.49
Current Revenue Per Employee
34600.00
Dividends Per Share - Security
N/A
EBITDA
-22.23M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-100.28
Shares Held By Institutions
21M
Shares Outstanding - Current
75.8M
Total Liabilities
64M
Total Volume MTD
N/A
Value
-1
Gain YTD
-12.821
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drug therapies to treat chronic, blinding diseases of the eye
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
900 North Point Parkway
Phone
+1 678 270-3631
Employees
30
Web
https://www.clearsidebio.com